🟢 ADMA Biologics is trading 54% up in after-hours trading; catalyst remains unclear

ADMA Biologics is trading 54% higher at $15.15 after-hours on September 22, 2026; no company-specific catalyst has been identified.

• The move follows a regular-session close of $9.81.
• No reliable company-specific announcement, earnings release, regulatory decision, or filing explaining the spike was identified. Available coverage lists the latest major company releases as earlier events, while broader markets were mixed.